Litcius/Paper detail

Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study

Richard N. van Zyl-Smit, Matthias Krüll, Christian Geßner, Yasuhiro Gon, O. Noga, Alexia Richard, Amy de los Reyes, Xu Shu, Abhijit Pethe, Ana-Maria Tanase, Peter D’Andrea

2020The Lancet Respiratory Medicine50 citationsDOI

Topics & Concepts

IndacaterolMedicineSalmeterolFluticasoneAsthmaInternal medicineDouble blindAnesthesiaBronchodilatorPlaceboAlternative medicinePathologyAsthma and respiratory diseasesPharmacological Effects and AssaysInhalation and Respiratory Drug Delivery